Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
Public ClinicalTrials.gov record NCT01943799. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to evaluate the safety and efficacy of GS-4774 in adults with chronic hepatitis B (CHB) viral infection who have been virally suppressed with an oral antiviral (OAV) medication.
Study identification
- NCT ID
- NCT01943799
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 178 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 13, 2013 (Actual)
- Primary completion
- Sep 9, 2014 (Actual)
- Completion
- Mar 3, 2015 (Actual)
- Last update posted
- Nov 1, 2019
2013 – 2015
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dumont-UCLA Liver Transplant Center | Los Angeles | California | 90095 | — |
| Huntington Medical Research Institutes | Pasadena | California | 91105 | — |
| Kaiser Permanente | Sacramento | California | 95825 | — |
| Kaiser Permanente | San Diego | California | 92154 | — |
| Kaiser Permanente | San Francisco | California | 94118 | — |
| Silicon Valley Research Institute | San Jose | California | 95128 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Digestive Disease Associates, PA | Baltimore | Maryland | 21229 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Hospital and Health System | Detroit | Michigan | 48202 | — |
| St.Louis University | St Louis | Missouri | 63104 | — |
| Medical Pro-care | Flushing | New York | 11355 | — |
| North Shore LIJ Health System | Manhasset | New York | 11030 | — |
| Bon Secours St. Mary's Hospital of Richmond | Newport News | Virginia | 23602 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01943799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01943799 live on ClinicalTrials.gov.